BOLZATI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.689
AS - Asia 1.135
EU - Europa 791
AF - Africa 259
SA - Sud America 245
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 14
Totale 5.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.546
SG - Singapore 393
CN - Cina 250
BR - Brasile 160
IT - Italia 138
HK - Hong Kong 131
DE - Germania 83
VN - Vietnam 83
FI - Finlandia 82
PL - Polonia 76
FR - Francia 45
NL - Olanda 40
SE - Svezia 38
RU - Federazione Russa 37
GB - Regno Unito 25
CI - Costa d'Avorio 18
IN - India 18
IE - Irlanda 17
ZA - Sudafrica 17
TR - Turchia 16
PY - Paraguay 15
AR - Argentina 14
BO - Bolivia 13
CA - Canada 13
JP - Giappone 13
NC - Nuova Caledonia 13
TH - Thailandia 13
UZ - Uzbekistan 13
KZ - Kazakistan 12
UA - Ucraina 12
CW - ???statistics.table.value.countryCode.CW??? 11
ES - Italia 11
GR - Grecia 11
IL - Israele 11
IS - Islanda 11
MG - Madagascar 11
AL - Albania 10
AT - Austria 10
HR - Croazia 10
HU - Ungheria 10
KR - Corea 10
LB - Libano 10
MX - Messico 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
CH - Svizzera 9
DZ - Algeria 9
EC - Ecuador 9
GT - Guatemala 9
IQ - Iraq 9
KH - Cambogia 9
PA - Panama 9
PR - Porto Rico 9
TW - Taiwan 9
UG - Uganda 9
AM - Armenia 8
BE - Belgio 8
BS - Bahamas 8
BW - Botswana 8
BY - Bielorussia 8
CO - Colombia 8
CY - Cipro 8
CZ - Repubblica Ceca 8
GE - Georgia 8
HN - Honduras 8
ME - Montenegro 8
NZ - Nuova Zelanda 8
SO - Somalia 8
AU - Australia 7
AZ - Azerbaigian 7
DJ - Gibuti 7
DO - Repubblica Dominicana 7
GA - Gabon 7
GM - Gambi 7
ID - Indonesia 7
LT - Lituania 7
LV - Lettonia 7
MK - Macedonia 7
MW - Malawi 7
MY - Malesia 7
PS - Palestinian Territory 7
RS - Serbia 7
SA - Arabia Saudita 7
TJ - Tagikistan 7
TL - Timor Orientale 7
TN - Tunisia 7
VE - Venezuela 7
ZW - Zimbabwe 7
BJ - Benin 6
CR - Costa Rica 6
CU - Cuba 6
EE - Estonia 6
GN - Guinea 6
HT - Haiti 6
LA - Repubblica Popolare Democratica del Laos 6
LC - Santa Lucia 6
LY - Libia 6
MQ - Martinica 6
MU - Mauritius 6
NI - Nicaragua 6
Totale 4.906
Salva come PNG Salva come JPEG
Città #
Fairfield 333
Singapore 267
Ashburn 266
Chandler 253
Woodbridge 181
Houston 177
Ann Arbor 163
Hong Kong 131
Santa Clara 113
Seattle 108
Cambridge 104
Wilmington 97
Beijing 75
Boardman 65
Bytom 60
Medford 39
Princeton 39
Dong Ket 38
Los Angeles 36
Padova 36
Munich 34
Des Moines 32
Helsinki 30
San Diego 28
Nanjing 23
Turku 20
New York 19
Abidjan 18
Ho Chi Minh City 17
Roxbury 16
Buffalo 15
Hefei 14
Dublin 13
Noumea 13
São Paulo 12
Brooklyn 10
Dakar 10
Milan 10
Tashkent 10
Willemstad 10
Antananarivo 9
Boston 9
Hanoi 9
Kampala 9
Redondo Beach 9
Belo Horizonte 8
Columbus 8
Nassau 8
Panama City 8
Reykjavik 8
Athens 7
Dallas 7
Dushanbe 7
Harare 7
Limassol 7
London 7
Phnom Penh 7
Tokyo 7
Warsaw 7
Almaty 6
Apia 6
Baku 6
Budapest 6
Castries 6
Dili 6
Guatemala City 6
Jiaxing 6
Johannesburg 6
Kigali 6
Libreville 6
Lusaka 6
Managua 6
Minsk 6
Montevideo 6
Nuremberg 6
Podgorica 6
Pune 6
Riga 6
Rio de Janeiro 6
Shenyang 6
Tel Aviv 6
Trieste 6
Vientiane 6
Amman 5
Amsterdam 5
Andorra la Vella 5
Asunción 5
Auckland 5
Bamako 5
Bangkok 5
Banjul 5
Belgrade 5
Cape Town 5
Changsha 5
Conakry 5
Cotonou 5
Djibouti 5
Falkenstein 5
Ferrara 5
Gaborone 5
Totale 3.312
Salva come PNG Salva come JPEG
Nome #
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study 187
[99mTc][Tc(N)(DASD)(PNPn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarbamate, PNPn=bisphosphinoamine) for myocardial imaging: synthesis, pharmacological and pharmacokinetic studies 185
[99mTc(N)PNP]-scaffold for SPECT of multidrug resistance: Early in-vitro study 184
Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer Cells 171
Melanoma targeting with [99mTc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 169
Synthesis and Characterization of [MIII(PS)2(L)] Mixed-Ligand Compounds (M = Re,99Tc; PS = Phosphinothiolate; L = Dithiocarbamate) as Potential Models for the Development of New Agents for SPECT Imaging and Radiotherapy 167
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 161
Biologically relevant Cu2+ complexes with a tridentate phenanthroline analogue: structural properties and DNA damage 157
Pharmacological characterization of α-MSH-derivatives 155
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 149
TcIII-based mixed complexes for the design and the development of new SPECT tracers 147
A bis(thiosemicarbazone) bifunctional chelating agent for nitrido-technetium-99m and copper-64 based radiopharmaceuticals 146
99mTc(N)(DASD)(pnpn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarba pnpn=bisphosphinoamine) for myocardial imaging 139
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)2NR diphosphinoamine ligands 138
99mTc(N)-DBODC(5) from cardiology to oncology: preliminary in vitro study 132
A bis(thiosemicarbazone) bifunctional chelating agent for Nitrido-Technetium-99m and Copper-64 based radiopharmaceuticals 132
Assessment of the best N3− donors in preparation of [M(N)(PNP)]-based (M=99mTc-; 188Re) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ) 128
Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals 126
Radiopharmacological characterization of 64Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma 123
Preclinical dosimetric studies of 177Lu-scFvD2B and comparison with 177Lu-PSMA-617 and 177Lu-iPSMA endoradiotherapeutic agents 120
[Re-188(N)(cys similar to)(PNP)](+/0) mixed ligand compounds as models for target specific agents 118
Synthesis and Characterization of Novel Hexacoordinated, Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 116
Radiation effective dose assessment of [51Mn]- and [52Mn]-chloride 115
Synthesis a new radiopharmaceutical for prostate cancer SPECT imaging 113
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations 112
[99mTc(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 112
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 108
64Cu-Labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies 106
Synthesis and biological evaluation of new [Tc(N)(R2PS)]-based mixed compounds as analogues of WAY 100635 106
Nitrido technetium-99m core in radiopharmaceutical applications: Four decades of research 104
[99mTc(N)(DASD)(PNPn)]+ Compounds as Myocardial Perfusion Imaging Agents. 104
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies 102
Conjugation and characterization of a new prostate cancer theranostic radiopharmaceutical 102
Comparison of preclinical dosimetric studies of 177Lu-scFvD2B, 177Lu-PSMA-617 and 177Lu-iPSMA. 98
99mTc(N)-DBODC(5), a potential probe for SPECT imaging of multidrug resistance: in vitro study 98
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 94
Dosimetry of 51MnCl2 and 52MnCl2 for PET application 94
Development of a new prostate cancer theranostic radiopharmaceutical 85
Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds 80
Zirconium immune-complexes for PET molecular imaging: Current status and prospects 78
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies 76
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 71
Totale 5.208
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.723
article - articoli 11.805
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 218
selected - selezionate 0
volume - volumi 0
Totale 29.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 27 10 12 5 39 34 55 37 71
2021/2022426 16 52 43 27 21 30 23 43 18 14 33 106
2022/2023474 78 59 9 76 72 56 4 22 50 14 25 9
2023/2024293 18 51 46 20 28 23 24 11 5 22 21 24
2024/20251.132 9 77 43 43 190 24 65 103 89 18 195 276
2025/20261.565 241 324 478 522 0 0 0 0 0 0 0 0
Totale 5.208